📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway. (2018)

First Author: Kidger AM

Attributed to: A systems approach to understanding lipid, Ca2+ and MAPK signalling networks funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.pharmthera.2018.02.007

PubMed Identifier: 29454854

Publication URI: http://europepmc.org/abstract/MED/29454854

Type: Journal Article/Review

Volume: 187

Parent Publication: Pharmacology & therapeutics

ISSN: 0163-7258